The first real-world study of the FDA-approved non-hormone treatment fezolinetant found the menopausal medication improved ...

Male rats that were exposed to the widely used plasticizer di-(2-ethylhexyl) phthalate (DEHP) during early development ...

People prescribed GLP-1 medications are more likely to start-and-stop than most people assume, according to a study being ...

Longer lifetime exposure to female hormones may increase the risk of thyroid cancer in women, according to a study being ...

Endocrine-disrupting chemicals (EDCs) that interfere with hormones were found in breast milk and in the urine of children ...

Only a small number of men who were prescribed testosterone therapy received appropriate, guideline-concordant diagnostic ...

Testosterone treatment may improve body composition, glucose metabolism and sexual desire in some older men at high risk of ...

Adults with obesity losing weight with glucagon-like peptide-1 (GLP-1) receptor agonist medications significantly decreased ...

A study of a new AI model examining 30 years of routine electronic health records (EHR) data could improve screening for ...

People with an organ transplant who develop or have existing diabetes are more likely to die than those without diabetes, ...

Eliminating sugar from your diet may be more detrimental than previously thought, according to an animal study being ...

Northwestern Medicine scientists have identified a safety concern associated with GLP-1 drugs. Using health record data, the ...